In SIF - seq, hundreds or thousands of DNA fragments to be tested for enhancer activity are coupled to a reporter gene and targeted into a single, reproducible site in
embryonic cell genomes.
Not exact matches
The ability of SIF - seq to use reporter assays in mouse
embryonic stem
cells to identify human
embryonic stem
cell enhancers that are not present in the mouse
genome opens the door to intriguing research possibilities as Dickel explains.
Using a mathematical model known as the Ising model, invented to describe phase transitions in statistical physics, such as how a substance changes from liquid to gas, the Johns Hopkins researchers calculated the probability distribution of methylation along the
genome in several different human
cell types, including normal and cancerous colon, lung and liver
cells, as well as brain, skin, blood and
embryonic stem
cells.
Derived mostly from human
embryonic kidney 293T (HEK293T) and HeLa
cell lines, EdiGene Knockout (KO) Cell Lysates have been optimized through the use of genome editing technology and validated at the genomic level through PCR and Sanger - sequencing techniques to ensure the accuracy and knockout of the target g
cell lines, EdiGene Knockout (KO)
Cell Lysates have been optimized through the use of genome editing technology and validated at the genomic level through PCR and Sanger - sequencing techniques to ensure the accuracy and knockout of the target g
Cell Lysates have been optimized through the use of
genome editing technology and validated at the genomic level through PCR and Sanger - sequencing techniques to ensure the accuracy and knockout of the target gene.
Mitchell and her colleagues eliminated this possibility when they deleted these nearby regions in the
genome of mice and found there was no impact on the gene's ability to be turned on in
embryonic stem
cells.
«We studied how the Sox2 gene is turned on in mice, and found the region of the
genome that is needed to turn the gene on in
embryonic stem
cells,» said Professor Jennifer Mitchell of U of T's Department of
Cell and Systems Biology, lead invesigator of a study published in the December 15 issue of Genes & Development.
«Though the degree to which human
embryonic stem
cells possess this feature is not entirely clear, by understanding how another complex organism's
genome works we ultimately learn more about how our own
genome works,» said Zhou.
Next, they found that the
genomes of naïve
embryonic stem
cells have less methylation — the addition of methyl chemical groups along DNA.
Not only did a high percentage of
embryonic cells get repaired, but also gene correction didn't induce any detectable off - target mutations and
genome instability — major concerns for gene editing.
An ambitious plan to map the
genome's regulatory elements will focus first on mouse
embryonic stem
cells.
The study, published today in the journal
Cell Stem
Cell and led by Dr. Shunsuke Ishii from RIKEN, sought to identify the molecule in the mammalian oocyte that induces the complete reprograming of the
genome leading to the generation of totipotent
embryonic stem
cells.
They accomplished this by using mouse
embryonic stem
cells to manipulate the mouse
genome at the very start of development.
Intact
genome from one particular mouse
embryonic stem
cell.
The researchers have illustrated the structure in accompanying videos, which show the intact
genome from one particular mouse
embryonic stem
cell.
Research led by the Babraham Institute with collaborators in the UK, Canada and Japan has revealed a new understanding of how an open
genome structure supports the long - term and unrestricted developmental potential in
embryonic stem
cells.
The IMPC envisages a ten year programme to undertake a broad - based, systematic
genome - wide phenotyping project of knockout mice generated from the
embryonic stem
cell mutant resources developed by the International Knock - out Mouse Consortium (IKMC).
In work published on 24 November in the journal Nature biotechnology, Anselme Perrier's team at I - Stem identified a recurrent anomaly in the
genome of human
embryonic stem
cells left in culture for too long.
On Aug. 3, the scientific article in Nature finally gave us some facts about the much - hyped experiments that involved editing the
genomes of human embryos at the Center for
Embryonic Cell and Gene Therapy at Oregon Health and Science University.
In partnership with several international programs, the initial five - year phase of KOMP will reach its goal of creating knockout mouse
embryonic stem
cell lines for each of the approximately 21,000 protein - coding genes in the mouse
genome this year.
The Repository of mouse ES
cell lines, strains and vectors generated by the trans - NIH KOMP initiative that aims to generate a public resource comprised of mouse
embryonic stem (ES)
cells containing a null mutation in every gene in the mouse
genome.
To conduct the experiments, the team will use state of the art
genome engineering technology to generate mutant
embryonic stem
cells at a large scale, followed by transcriptional profiling via next generation sequencing.
To find those genes, Yamanaka had compared all the genes (the
genome) of an
embryonic stem
cell with those of an adult
cell to find genes that were turned on in the ES
cell but turned off in the adult
cell.
Henk Stunnenberg, leader of one of the research groups that carried out the study and coordinator of both Heroic and the recently started High Impact Project BLUEPRINT, said: «The epigenetic make - up - a layer of regulatory instructions on top of the
genome - of the pure
embryonic stem
cells shows remarkable and unexpected features, in particular with respect to developmental genes.
However, during prolonged culture one of eight
embryonic stem
cell lines showed a resurgence of the spindle donor's mitochondrial
genome.
Stem
cell researchers from UCLA used a high resolution technique to examine the
genome, or total DNA content, of a pair of human
embryonic stem
cell lines and found that while both lines could form neurons, the lines had differences in the numbers of certain genes that could control such things as individual traits and disease susceptibility.
A
genome - scale RNAi screen for Oct4 modulators defines a role of the Paf1 complex for
embryonic stem
cell identity.
With the new SIF - seq technique, mouse
embryonic stem
cells can be used to identify human
embryonic stem
cell enhancers even when the human enhancers are not present in the mouse
genome.
Title: A
genome - wide RNAi screen reveals MAP kinase phosphatases as key ERK pathway regulators during
embryonic stem
cell differentiation (IN PRESS, Oct 2012) Authors: Sharrocks A, Yang S - H, Kalkan T, Haslam C, Smith A Date: IN PRESS, Oct 2012 Publication Details: PLoS Genetics
Reference: September 13, 2007 issue of
Cell Stem
Cell under the title «Whole -
Genome Mapping of Histone H3Lys4 and 27 Trimethylations Reveals Distinct Genomic Compartments in Human
Embryonic Stem
Cells».
Embryonic stem
cells with identical
genomes grow into distinctive tissues, such as heart, bone, and brain.
In their latest study, the group conducted a
genome wide screening by developing a novel primary mouse
embryonic stem
cell line that enhances the efficiency of CRISPR - Cas9 mediated mutations.
Topics covered include
embryonic stem
cells, pluripotency, germline stem
cells, tissue - specific stem
cells, stem
cell differentiation, epigenetics, stem
cell genomics and systems biology,
genome reprogramming, cancer stem
cells, stem
cell niches, stem -
cell - based disease models, nuclear transfer technology, bioengineering, drug discovery, in vivo imaging of stem
cells, therapeutic applications, regenerative medicine, clinical and translational insights, stem
cell research policies, ethical issues, and technical or resource - based innovations.
During
embryonic development,
cells use the information contained in their
genome to build the organism.
The scientists had strategically inserted these foreign DNA «markers» at particular points along the
genome, next to genes expressed only in
embryonic stem
cells.
To develop the methodology, the group analyzed the molecular profiles of human
embryonic stem
cells and compared them with data for 12,000 samples of 33 different tumor types held by The Cancer
Genome Atlas (TCGA), a U.S. public database.
The Knockout Mouse Project (KOMP & KOMP2) is a trans - NIH initiative that aims to generate a comprehensive and public resource comprised of mouse
embryonic stem (ES)
cells containing a null mutation in every gene in the mouse
genome.
Here we used
genome - saturated mutagenesis to create a biobank of over 100,000 individual haploid mouse
embryonic stem (mES)
cell lines targeting 16,970 genes with genetically barcoded, conditional and reversible mutations.
In the November 6 Nature Methods, the team led by Bing Lim and Massimo Nichane of the
Genome Institute of Singapore and Kyle M. Loh of Stanford University School of Medicine, and including Siva V, Ph.D., of The Jackson Laboratory's Single
Cell Biology Lab, showed that mouse Sox9 + multipotent
embryonic lung progenitors can be isolated and expanded long - term in 3D culture.